Yeh, W. Z. Et Al. 2024. Disease Activity in Pregnant and Postpartum Women With Multiple Sclerosis Receiving Ocrelizumab or Other Disease-Modifying Therapies. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION , vol.11, no.6 .

Yeh, W. Z., van der Walt, A., Skibina, O. G., Kalincik, T., Alroughani, R., Kermode, A. G., ... Fabis-Pedrini, M. J.(2024). Disease Activity in Pregnant and Postpartum Women With Multiple Sclerosis Receiving Ocrelizumab or Other Disease-Modifying Therapies. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION , vol.11, no.6.

Yeh, Wei Et Al. "Disease Activity in Pregnant and Postpartum Women With Multiple Sclerosis Receiving Ocrelizumab or Other Disease-Modifying Therapies," NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION , vol.11, no.6, 2024

Yeh, Wei Z. Et Al. "Disease Activity in Pregnant and Postpartum Women With Multiple Sclerosis Receiving Ocrelizumab or Other Disease-Modifying Therapies." NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION , vol.11, no.6, 2024

Yeh, W. Z. Et Al. (2024) . "Disease Activity in Pregnant and Postpartum Women With Multiple Sclerosis Receiving Ocrelizumab or Other Disease-Modifying Therapies." NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION , vol.11, no.6.

@article{article, author={Wei Z. Yeh Et Al. }, title={Disease Activity in Pregnant and Postpartum Women With Multiple Sclerosis Receiving Ocrelizumab or Other Disease-Modifying Therapies}, journal={NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION}, year=2024}